8-K

Company

Nautilus Biotechnology, Inc.

Filed

June 13, 2024

Period of Report

June 13, 2024

Accession Number

0001808805-24-000043

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →